Accelerate neoantigen-based immunotherapy development for cancer treatment

Overcome challenges in neoantigen-based immunotherapy development and leverage synthetic peptides for cancer treatment.

Synthetic peptides are indispensable across all phases of immunotherapy, from discovery and development to manufacturing. Identifying neoantigen peptides is essential for creating personalized cancer vaccines and T cell therapies, driving the advancement of highly targeted and effective treatments.

This eBook aims to address the significant challenges faced by scientists and laboratory professionals in the timely generation of reagents essential for accelerating patient therapies.

Download to learn more about:

• The applications of synthetic peptides
• Advancing shared neoantigen-based immunotherapies
• Validating neoantigen-reactive T-cell receptors
• Bioinformatics tools for peptide synthesis
• Rapid cGMP peptide manufacturing
• Neoantigen peptide synthesis for precision therapeutics
• Developing personalized neoantigen vaccines